These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2259004)

  • 1. [Apolipoprotein E phenotypes and psoriasis].
    Imamura T; Takata I; Tominaga K; Yamamoto T; Ogasawara M; Asagami C
    Nihon Hifuka Gakkai Zasshi; 1990 Aug; 100(9):923-8. PubMed ID: 2259004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin.
    Campalani E; Allen MH; Fairhurst D; Young HS; Mendonca CO; Burden AD; Griffiths CE; Crook MA; Barker JN; Smith CH
    Br J Dermatol; 2006 Feb; 154(2):345-52. PubMed ID: 16433808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E5 and E7 in apparently healthy Japanese males: frequencies and relation to plasma lipid levels.
    Yamanouchi Y; Arinami T; Tsuchiya S; Miyazaki R; Takaki H; Takano T; Hamaguchi H
    Jpn J Hum Genet; 1994 Sep; 39(3):315-24. PubMed ID: 7841442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of apolipoprotein allele epsilon 2 with psoriasis vulgaris in Japanese population.
    Furumoto H; Nakamura K; Imamura T; Hamamoto Y; Shimizu T; Muto M; Asagami C
    Arch Dermatol Res; 1997 Aug; 289(9):497-500. PubMed ID: 9341968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein epsilon4 allele is associated with psoriasis severity.
    Coto-Segura P; Coto E; Alvarez V; Morales B; Soto-Sánchez J; Corao AI; Santos-Juanes J
    Arch Dermatol Res; 2010 Mar; 302(2):145-9. PubMed ID: 19911187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E polymorphism in India: high APOE*E3 allele frequency in Ramgarhia of Punjab.
    Singh P; Singh M; Gerdes U; Mastana SS
    Anthropol Anz; 2001 Mar; 59(1):27-34. PubMed ID: 11360807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apolipoprotein E gene polymorphisms and Alzheimer disease].
    Chen D; Zhang JW; Zhang ZX; Zhao HL; Li XQ; Wu YN; Qu QM
    Yi Chuan Xue Bao; 2003 Dec; 30(12):1167-70. PubMed ID: 14986436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T; Zhou X; Jin W; Zheng F; Cao X
    Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E polymorphism in elderly east Africans.
    Sayi JG; Patel NB; Premkumar DR; Adem A; Winblad B; Matuja WB; Mtui EP; Gatere S; Friedland RP; Koss E; Kalaria RN
    East Afr Med J; 1997 Oct; 74(10):668-70. PubMed ID: 9529753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan.
    Nakayama S; Kuzuhara S
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):643-8. PubMed ID: 10687744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between apolipoprotein E gene polymorphism and the patients with persistent vegetative state in the Chinese].
    Hu XF; Zhang XR; Xue A; Cao XR
    Yi Chuan Xue Bao; 2002 Sep; 29(9):757-60. PubMed ID: 12561220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus.
    Wozniak MA; Itzhaki RF; Faragher EB; James MW; Ryder SD; Irving WL;
    Hepatology; 2002 Aug; 36(2):456-63. PubMed ID: 12143056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.
    Akanji AO; Ohaeri JU; Al-Shammri SN; Fatania HR
    Neuropsychobiology; 2009; 60(2):67-72. PubMed ID: 19752580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E gene polymorphism in psoriasis.
    Karpouzis A; Caridha R; Tripsianis G; Michailidis C; Martinis G; Veletza SV
    Arch Dermatol Res; 2009 Jul; 301(6):405-10. PubMed ID: 19499236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it.
    Martorell L; Virgos C; Valero J; Coll G; Figuera L; Joven J; Pocoví M; Labad A; Vilella E
    Mol Psychiatry; 2001 May; 6(3):307-10. PubMed ID: 11326299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].
    Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI
    Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population].
    Wu YN; Zhang JW; Zhang ZX; Qu QM; Chen D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):450-4. PubMed ID: 12905860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
    Duman BS; Oztürk M; Yilmazer S; Hatemi H
    Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of HLA-Cw*06 allele frequency with some clinical features of psoriasis vulgaris in the population of northern Poland.
    Szczerkowska-Dobosz A; Rebała K; Szczerkowska Z; Witkowska-Toboła A
    J Appl Genet; 2004; 45(4):473-6. PubMed ID: 15523160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of APOE genetic polymorphism with susceptibility to multiple sclerosis and its clinical phenotypes in Kuwaiti Arab subjects.
    Al-Shammri S; Fatania H; Al-Radwan R; Akanji AO
    Clin Chim Acta; 2005 Jan; 351(1-2):203-7. PubMed ID: 15563891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.